Leprosy, or Hansen’s disease (HD), is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. Symptoms may include loss of sensation, reddish skin lesions, and weakness of muscles. Leprosy can be spread by coming in contact with the cough or phlegm of an affected person. Other risk factors of leprosy include malnutrition and weak immune system. It is curable and treatment in the early stages can prevent disability.
Request For A Sample Of The Leprosy Treatment Market Report: https://www.coherentmarketinsights.com/insight/request-sample/128
Increasing prevalence of leprosy around the world is expected to boost the growth of the global leprosy treatment market over the forecast period. For instance, according to the World Health Organization (WHO), there were approximately 176,176 cases of leprosy (0.18 cases per 10000 people) in 2015 in different parts of the world (138 countries). Furthermore, global figures show that 203,600 (96%) of the fresh leprosy cases were from 22 major countries.
Moreover, government support for the development of leprosy treatment is expected to propel growth of the global leprosy treatment market. According to the WHO, about 16 million cases of leprosy have been treated in the past two decades.
Although various drugs are available for end-stage leprosy treatment, early detection of disease is an important factor for effective treatment. Multidrug therapy is the most common treatment for leprosy. Clofazimine, dapsone, and rifampicin are some of the WHO recommended drugs. Some of the other drugs available for the treatment of leprosy are Rimactane and Rifadine. This in turn is expected to drive growth of the market.
Among regions, Asia Pacific is expected to witness substantial growth in the global leprosy treatment market due to the high prevalence of leprosy and favorable government initiatives in this region. For instance, according to the Leprosy Mission Trust, in 2013-14, around 127,000 new cases of leprosy were registered in India. Of which, around 46% were women and children. Moreover, the Government of India launched the National Leprosy Eradication Programme (NLEP) to get rid of the disease from the country by 2018.
Request PDF Brochure with Latest Insights @
Key players active in the global leprosy treatment market are Systopic Laboratories Pvt. Ltd., Cadila Pharmaceuticals, Macleods Pharmaceuticals, Astra Zeneca Pharma India Ltd., IDPL, Lark Laboratories (UIndia) Ltd., Novartis International AG., Acme Pharmaceuticals, Genetic Pharma, and Glaxo Smithcline Pharmaceuticals Ltd., among others.
In February 2019, Novartis announced that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older.
In March 2019, Novartis Foundation and Microsoft teamed up to develop AI-enabled digital health tool and a leprosy intelligent image atlas to boost the early detection of leprosy.
In September 2018, Infectious Disease Research Institute and HDT Biotech Corp. teamed up to develop cost-effective test to detect infection with M. leprae, which causes leprosy.
By Type of Leprosy:
- Early and indeterminate leprosy treatment
- Borderline tuberculoid leprosy treatment
- Tuberculoid leprosy treatment
- Borderline leprosy treatment
- Histoid leprosy treatment
- Lepromatous leprosy treatment
- Borderline lepromatous leprosy treatment
- Diffuse leprosy of Lucio and Latapí
- Multidrug Therapy
By End User:
- Medical Practitioners
Reasons to Buy this Leprosy Treatment Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Leprosy Treatment market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Leprosy Treatment market
➡Leading company profiles reveal details of key Leprosy Treatment market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Leprosy Treatment market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Leprosy Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Leprosy Treatment Industry Impact
Chapter 2 Global Leprosy Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Leprosy Treatment (Volume and Value) by Type
2.3 Global Leprosy Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Leprosy Treatment Sales, Consumption, Export, Import by Regions
Chapter 5 North America Leprosy Treatment Market Analysis
Chapter 6 East Asia Leprosy Treatment Market Analysis
Chapter 7 Europe Leprosy Treatment Market Analysis
Chapter 8 South Asia Leprosy Treatment Market Analysis
Chapter 9 Southeast Asia Leprosy Treatment Market Analysis
Chapter 10 Middle East Leprosy Treatment Market Analysis
Chapter 11 Africa Leprosy Treatment Market Analysis
Chapter 12 Oceania Leprosy Treatment Market Analysis
Chapter 13 South America Leprosy Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Leprosy Treatment Business
Chapter 15 Global Leprosy Treatment Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027